CAI Stock: Price, Earnings History and SEC Filings
Caris Life Sciences, Inc. (CAI) last traded at $34.33, down 5.01% on the latest session and up 12.1% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.00 against an analyst estimate of $-0.01, a beat of 100.0%.
$34.33 -5.01%
1 month+12.08%
52-week high$36.50
52-week low$14.19
Volume3.67M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
CAI earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $0.00 | $-0.01 | +100.00% |
| Mar 2026 | May 7, 2026 | $0.00 | $-0.02 | +100.00% |
| Dec 2025 | Feb 26, 2026 | $0.28 | $0.01 | +2700.00% |
| Sep 2025 | Nov 5, 2025 | $0.08 | $-0.08 | +200.00% |
CAI beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
CAI financial history
Revenue
Net income
Free cash flow
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $812M | -$68M | $67M | -8.4% | $-3.22 |
| 2024 | $412M | -$282M | -$254M | -68.4% | $-10.66 |
| 2023 | $306M | -$341M | -$298M | -111.5% | $-13.24 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for CAI
SEC filing data is not available right now. You can search for CAI on SEC EDGAR.
CAI news
- Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?Oct 29, 2026 · finance.yahoo.com
- Analysts Estimate Caris Life Sciences,?Inc. (CAI) to Report a Decline in Earnings: What to Look Out forOct 28, 2026 · finance.yahoo.com
- Foundation Medicine Appoints Chadi Nabhan, M.D., MBA, as Chief Medical OfficerOct 22, 2026 · finance.yahoo.com
- Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer DetectionOct 19, 2026 · finance.yahoo.com
About Caris Life Sciences, Inc.
Caris Life Sciences, Inc. (CAI) is a US-listed public company on Nasdaq.